Lakefront Biotherapeutics NV (LKFT) — Long-term Investment Intensity
Lakefront Biotherapeutics NV (LKFT) has a Long-term Investment Intensity of 2.2% as of June 2026. Long-term investments of $73.86 Million represent 2.2% of total assets of $3.35 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See LKFT current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Lakefront Biotherapeutics NV Long-term Investment Intensity (2023–2025)
This chart shows how Lakefront Biotherapeutics NV's Long-term Investment Intensity has evolved across 3 annual periods from 2023 to 2025. As of June 2026, the intensity stands at 2.2%, reflecting long-term investments of $73.86 Million against total assets of $3.35 Billion USD. See Lakefront Biotherapeutics NV (LKFT) liquidity interval to measure how many days the company can operate on defensive assets alone.
Annual Long-term Investment Intensity for Lakefront Biotherapeutics NV (2023–2025)
The table below presents the year-by-year Long-term Investment Intensity for Lakefront Biotherapeutics NV from 2023 to 2025, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see balance sheet size of Lakefront Biotherapeutics NV.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 1.4% | $46.81 Million | $3.41 Billion | ▼ -4.7 pp |
| 2024 | 6.1% | $253.12 Million | $4.14 Billion | ▲ +5.8 pp |
| 2023 | 0.3% | $13.57 Million | $4.36 Billion | — |